Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment.

The tumour microenvironment regulates tumour progression and the spread of cancer in the body. Targeting the stromal cells that surround cancer cells could, therefore, improve the effectiveness of existing cancer treatments. Here, we show that magnetic nanoparticle clusters encapsulated inside a liposome can, under the influence of an external magnet, target both the tumour and its microenvironment. We use the outstanding T2 contrast properties (r2=573-1,286 s(-1) mM(-1)) of these ferri-liposomes, which are ∼95 nm in diameter, to non-invasively monitor drug delivery in vivo. We also visualize the targeting of the tumour microenvironment by the drug-loaded ferri-liposomes and the uptake of a model probe by cells. Furthermore, we used the ferri-liposomes to deliver a cathepsin protease inhibitor to a mammary tumour and its microenvironment in a mouse, which substantially reduced the size of the tumour compared with systemic delivery of the same drug.

[1]  Vladimir Torchilin,et al.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  Q. Deveraux,et al.  Comprehensive search for cysteine cathepsins in the human genome , 2004, Biological chemistry.

[3]  J. Joyce,et al.  Cysteine Cathepsins and the Cutting Edge of Cancer Invasion , 2007, Cell cycle.

[4]  J. Bulte,et al.  Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran‐magnetite particles , 1993, Magnetic resonance in medicine.

[5]  Florence Gazeau,et al.  Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility. , 2006, Radiology.

[6]  O. Vasiljeva,et al.  Emerging roles of cysteine cathepsins in disease and their potential as drug targets. , 2007, Current pharmaceutical design.

[7]  J. Bulte,et al.  Short‐ vs. long‐circulating magnetoliposomes as bone marrow‐seeking MR contrast agents , 1999, Journal of magnetic resonance imaging : JMRI.

[8]  Sung Tae Kim,et al.  Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. , 2007, Angewandte Chemie.

[9]  Bonnie F. Sloane,et al.  Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. , 2005, Seminars in cancer biology.

[10]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[11]  D. Hanahan,et al.  Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer. , 2007, Cancer research.

[12]  D. Hanahan,et al.  Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. , 2004, Cancer cell.

[13]  E. Puré,et al.  Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. , 2009, The Journal of clinical investigation.

[14]  Chad A Mirkin,et al.  Nanostructures in biodiagnostics. , 2005, Chemical reviews.

[15]  Mikhail G. Shapiro,et al.  Dynamic imaging with MRI contrast agents: quantitative considerations. , 2006, Magnetic resonance imaging.

[16]  Thomas Kelly,et al.  In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. , 2009, Nature nanotechnology.

[17]  A. Burlingame,et al.  Chemical Approaches for Functionally Probing the Proteome* , 2002, Molecular & Cellular Proteomics.

[18]  Bonnie F. Sloane,et al.  Cysteine cathepsins: multifunctional enzymes in cancer , 2006, Nature Reviews Cancer.

[19]  O. Vasiljeva,et al.  Dual contrasting roles of cysteine cathepsins in cancer progression: apoptosis versus tumour invasion. , 2008, Biochimie.

[20]  Anna Moore,et al.  In vivo imaging of siRNA delivery and silencing in tumors , 2007, Nature Medicine.

[21]  R. Cardiff,et al.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.

[22]  Bernhard Gleich,et al.  Magnetic and Acoustically Active Lipospheres for Magnetically Targeted Nucleic Acid Delivery , 2010 .

[23]  J. Duerk,et al.  Magnetite‐Loaded Polymeric Micelles as Ultrasensitive Magnetic‐Resonance Probes , 2005 .

[24]  Valérie Cabuil,et al.  Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. , 2005, Journal of the American Chemical Society.

[25]  J. Dobson.  Magnetic nanoparticles for drug delivery , 2006 .

[26]  C. Tacchetti,et al.  Liposome-mediated therapy of neuroblastoma. , 2009, Methods in enzymology.

[27]  Michael F. Flessner,et al.  Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence , 2010, Nature Reviews Clinical Oncology.

[28]  V. Zharov,et al.  Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents. , 2009, Nature nanotechnology.

[29]  E. Rummeny,et al.  Rectal carcinoma: high-spatial-resolution MR imaging and T2 quantification in rectal cancer specimens. , 2006, Radiology.

[30]  M. Bogyo,et al.  Design, synthesis, and evaluation of in vivo potency and selectivity of epoxysuccinyl-based inhibitors of papain-family cysteine proteases. , 2007, Chemistry & biology.

[31]  J. Bulte,et al.  Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent , 1999 .

[32]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[33]  C. Contag,et al.  Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice , 2007, Proceedings of the National Academy of Sciences.

[34]  J. Kos,et al.  Cysteine cathepsins (proteases)--on the main stage of cancer? , 2004, Cancer cell.

[35]  J. Joyce,et al.  IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. , 2010, Genes & development.

[36]  M. Bogyo,et al.  Trial of the cysteine cathepsin inhibitor JPM-OEt on early and advanced mammary cancer stages in the MMTV-PyMT-transgenic mouse model , 2008, Biological chemistry.

[37]  Norio Tada,et al.  A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. , 2009, Nature nanotechnology.

[38]  A. Burlingame,et al.  Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. , 2000, Chemistry & biology.

[39]  A. Jasanoff,et al.  Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin , 2006, Proceedings of the National Academy of Sciences.

[40]  R. Weissleder,et al.  Trapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid: preparation of ferrosomes. , 1994, Biochimica et biophysica acta.

[41]  O. Vasiljeva,et al.  Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice , 2008, Oncogene.

[42]  O. Vasiljeva,et al.  Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice , 2010, Proceedings of the National Academy of Sciences.

[43]  J. Santamaría,et al.  Magnetic nanoparticles for drug delivery , 2007 .

[44]  O. Vasiljeva,et al.  Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. , 2006, Cancer research.

[45]  Dwight G Nishimura,et al.  FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents , 2006, Nature materials.

[46]  Jinwoo Cheon,et al.  Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging , 2007, Nature Medicine.

[47]  A A Bogdanov,et al.  Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. , 1994, Biochimica et biophysica acta.

[48]  Ralph Weissleder,et al.  Magnetic sensors for protease assays. , 2003, Angewandte Chemie.